2021 Early Screening, Early Diagnosis, Strong Grassroots Health, China Public Welfare Project Released

2021-04-23

On April 23, the Guangtai medical team participated in the Taihu Bay Life and Health Future Conference held in Wuxi. At the meeting, AstraZeneca, a partner of Guangtai Medical, held an annual ecosystem conference with the theme of "Creating the Future". It discussed with more than 600 partners the joint model of medicine and equipment, diagnostic cooperation model, business promotion model and investment model, presenting innovative solutions in different sub-sectors. Partners will also use this platform to learn about AstraZeneca's successful business innovation model and strategic planning, and to collaborate extensively in cross-learning.

At the meeting, the five-disease and five-cancer screening vehicle developed and designed by Guangtai Medical was officially unveiled, and participated in the release of the project of "2021 Early Screening and Early Diagnosis, Strong Grassroots, Healthy China Charity" sponsored by China Social Assistance Foundation and jointly supported by Guangtai Medical, AstraZeneca, Philips, Beckman and other enterprises. Li Tao, Executive Secretary of China Social Assistance Foundation, Xu Jing, Vice President of AstraZeneca China, Li Wenxuan, General Manager of Weihai Guangtai Group, Li Hui, General Manager of Weihai Guangtai Medical, Wu Taotao, General Manager of Philips Group, Jiang Zhiming, Global Vice President of Beckman and General Manager of China, jointly opened the launch ceremony.

As a representative of the public welfare bank supporting enterprises, Mr. Li Wenxuan, general manager of Weihai Guangtai Group, delivered a speech: participating in this public welfare activity is Guangtai's obligation and responsibility to build a national industry. Guangtai will, as always, stick to the road of innovation, build more professional mobile medical support equipment, truly open up the last kilometer of precision medicine, and make contributions to healthy Chinese 2030.

The public welfare line for screening five diseases and five cancers takes the mobile screening vehicle as the realization carrier, and cooperates with the high-quality medical personnel resources of 3A hospitals to build a movable "five diseases and five cancers" early screening service station. The vehicle is equipped with low-dose spiral CT, ultrasound, intelligent AI reader and other equipment, which can carry out B- ultrasound, CT, blood drawing, urine and other examinations, and produce the examination results on site, covering the vast grass-roots areas that lack medical resources such as professional testing equipment or testing personnel, we will carry out early screening, early diagnosis and treatment of the five common cancers and five chronic diseases for high-risk groups, and bring high-quality integrated diagnosis and treatment technology to the grass-roots people.

The meeting also launched a mobile screening white paper content solicitation activities, writing content direction for public value, cross-border collaboration, model innovation, quality indicators, to lay the foundation for the standardization of mobile screening.

In the future, Guangtai Medical will be based on the five disease and five cancer screening units, with patient-centered, multi-field, multi-disciplinary and cross-border cooperation, forming a series of multi-scene and multi-disease mobile medical units, and better realize the people's "Affordable, see good disease" healthy Chinese dream.

Key words:

CMEF｜广泰医疗多款移动医疗单元亮相展会

Guangtai Medical | Our "Five Diseases and Five Cancers" Screening Vehicle Leaves!